DEA Boosts Psychedelics Production For Research, Cannabis Quotas Hold Steady Ahead Of Rescheduling
The Drug Enforcement Administration (DEA) has unveiled new production quotas for Schedule I and II controlled substances, with a notable emphasis on boosting the supply of certain psychedelics for research purposes. As Marijuana Moment reported, among the substances marked for increased production are psilocybin, psilocyn and ibogaine, reflecting growing scientific interest ...
IbogaQuest launches a new therapeutic protocol to enhance
Leading the way in comprehensive post-Ibogaine care
Tepoztlan, Morelos, Mexico – IbogaQuest, one of the oldest and most respected ibogaine treatment centers in Mexico, is proud to announce the launch of a new therapeutic protocol designed to improve the long-term effectiveness of ibogaine treatment for mental and spiritual health, C-PTSD, ...
What to know about a vote to legalize psychedelic drugs
Massachusetts primary election guide 2022
Everything you need to know about voting in Massachusetts’ primary election on Sept. 6.
Waldy Diez, Wochit
In addition to deciding their pick for president of United ...
Oxa-Iboga alkaloids lack cardiac risk and disrupt opioid use in animal models
Ethical considerations
All experimental procedures involving animals were approved by the Columbia University, Memorial Sloan Kettering Cancer Center, Rutgers University or High Point University Institutional Animal Care and Use Committee (IACUC) and adhered to principles described in the National Institutes of Health Guide for the Care and Use of Laboratory Animals and abide by the ARRIVE guidelines.
All human hearts used for the present study were not suitable for transplantation and originated ...